Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies xGen Respiratory Virus Amplicon Panel

Integrated DNA Technologies has launched the xGen Respiratory Virus Amplicon Panel, which consists of primers designed to cover more than 98 percent of the genomes of respiratory syncytial virus A, RSV B, influenza A H1N1, influenza A H3N2, influenza B, and SARS-CoV-2. IDT's xGen amplicon technology uses overlapping primer sets and a single-tube workflow, with a sample-to-sequencer time of 2.5 hours, and genome coverage from viral titers as low as 10 to 100 viral copies.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.